Injective has broken out of a cup-and-handle pattern and recently tested the support zone around $6. As long as it holds, analyst Ali Martinez believes a rally toward $18 is possible. However, the MACD is nearing a bearish crossover below the zero line, indicating momentum favors sellers, while the price has not yet reclaimed the $9.60 resistance. The weekly structure remains bearish, although 47% of the INJ supply is currently staked, reinforcing long-term holder conviction and making a 51% attack prohibitively costly. The bullish scenario could therefore continue if $6.41 support holds before the market looks for selling opportunities above $9.60.
Source: Read the original article


